153 related articles for article (PubMed ID: 25420090)
1. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
Lan Y; Chen Y; Cao X; Zhang J; Wang J; Xu X; Qiu Y; Zhang T; Liu X; Liu BF; Zhang G
J Med Chem; 2014 Dec; 57(24):10404-23. PubMed ID: 25420090
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of novel 6,7-dihydro-5H-cyclopenta[d]pyrimidine and 5,6,7,8-tetrahydroquinazoline derivatives as sigma-1 (σ1) receptor antagonists for the treatment of pain.
Lan Y; Songyang Y; Zhang L; Peng Y; Song J
Bioorg Med Chem Lett; 2016 Apr; 26(8):2051-6. PubMed ID: 26947609
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Novel σ1 Receptor Ligands for Treating Neuropathic Pain: 6-Hydroxypyridazinones.
Cao X; Chen Y; Zhang Y; Lan Y; Zhang J; Xu X; Qiu Y; Zhao S; Liu X; Liu BF; Zhang G
J Med Chem; 2016 Apr; 59(7):2942-61. PubMed ID: 27003636
[TBL] [Abstract][Full Text] [Related]
4. Optimization of bifunctional piperidinamide derivatives as σ
Xiong J; Zhuang T; Ma Y; Xu J; Ye J; Ma R; Zhang S; Liu X; Liu BF; Hao C; Zhang G; Chen Y
Eur J Med Chem; 2021 Dec; 226():113879. PubMed ID: 34628236
[TBL] [Abstract][Full Text] [Related]
5. Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
Xiong J; Jin J; Gao L; Hao C; Liu X; Liu BF; Chen Y; Zhang G
Eur J Med Chem; 2020 Apr; 191():112144. PubMed ID: 32087465
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic.
Lan Y; Chen Y; Xu X; Qiu Y; Liu S; Liu X; Liu BF; Zhang G
Eur J Med Chem; 2014 May; 79():216-30. PubMed ID: 24735647
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862).
Díaz JL; Cuberes R; Berrocal J; Contijoch M; Christmann U; Fernández A; Port A; Holenz J; Buschmann H; Laggner C; Serafini MT; Burgueño J; Zamanillo D; Merlos M; Vela JM; Almansa C
J Med Chem; 2012 Oct; 55(19):8211-24. PubMed ID: 22784008
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship study of a new series of selective σ(1) receptor ligands for the treatment of pain: 4-aminotriazoles.
Díaz JL; Christmann U; Fernández A; Torrens A; Port A; Pascual R; Álvarez I; Burgueño J; Monroy X; Montero A; Balada A; Vela JM; Almansa C
J Med Chem; 2015 Mar; 58(5):2441-51. PubMed ID: 25658964
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors.
Atwal KS; O'Neil SV; Ahmad S; Doweyko L; Kirby M; Dorso CR; Chandrasena G; Chen BC; Zhao R; Zahler R
Bioorg Med Chem Lett; 2006 Sep; 16(18):4796-9. PubMed ID: 16870436
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of Sigma-1 (σ
Cao X; Yao Z; Dou F; Zhang Y; Qiu Y; Zhao S; Xu X; Liu X; Liu BF; Chen Y; Zhang G
Chem Biodivers; 2019 Mar; 16(3):e1800599. PubMed ID: 30549193
[TBL] [Abstract][Full Text] [Related]
11. Development of New Benzylpiperazine Derivatives as σ
Romeo G; Bonanno F; Wilson LL; Arena E; Modica MN; Pittalà V; Salerno L; Prezzavento O; McLaughlin JP; Intagliata S
ACS Chem Neurosci; 2021 Jun; 12(11):2003-2012. PubMed ID: 34019387
[TBL] [Abstract][Full Text] [Related]
12. Improving selectivity preserving affinity: new piperidine-4-carboxamide derivatives as effective sigma-1-ligands.
Zampieri D; Laurini E; Vio L; Fermeglia M; Pricl S; Wünsch B; Schepmann D; Mamolo MG
Eur J Med Chem; 2015 Jan; 90():797-808. PubMed ID: 25528334
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
[TBL] [Abstract][Full Text] [Related]
14. High-affinity, selective σ ligands of the 1,2,3,4-tetrahydro-1,4'-silaspiro[naphthalene-1,4'-piperidine] type: syntheses, structures, and pharmacological properties.
Tacke R; Bertermann R; Burschka C; Dörrich S; Fischer M; Müller B; Meyerhans G; Schepmann D; Wünsch B; Arnason I; Bjornsson R
ChemMedChem; 2012 Mar; 7(3):523-32. PubMed ID: 22076883
[TBL] [Abstract][Full Text] [Related]
15. Novel highly potent and selective sigma 1 receptor antagonists related to spipethiane.
Piergentili A; Amantini C; Del Bello F; Giannella M; Mattioli L; Palmery M; Perfumi M; Pigini M; Santoni G; Tucci P; Zotti M; Quaglia W
J Med Chem; 2010 Feb; 53(3):1261-9. PubMed ID: 20067271
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and metabolic characterisation of the potent sigma1 receptor ligand 1'-benzyl-3-methoxy-3H-spiro[[2]benzofuran-1,4'-piperidine].
Wiese C; Grosse Maestrup E; Schepmann D; Vela JM; Holenz J; Buschmann H; Wünsch B
J Pharm Pharmacol; 2009 May; 61(5):631-40. PubMed ID: 19406002
[TBL] [Abstract][Full Text] [Related]
17. Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release in the spinal cord in rats.
Vidal-Torres A; Fernández-Pastor B; Carceller A; Vela JM; Merlos M; Zamanillo D
J Neurochem; 2014 May; 129(3):484-94. PubMed ID: 24384038
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
[TBL] [Abstract][Full Text] [Related]
19. New combination of pharmacophoric elements of potent σ₁ ligands: design, synthesis and σ receptor affinity of aminoethyl substituted tetrahydrobenzothiophenes.
Harel D; Schepmann D; Wünsch B
Eur J Med Chem; 2013 Nov; 69():490-7. PubMed ID: 24095744
[TBL] [Abstract][Full Text] [Related]
20. Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists.
Chen C; Wilcoxen KM; Huang CQ; Xie YF; McCarthy JR; Webb TR; Zhu YF; Saunders J; Liu XJ; Chen TK; Bozigian H; Grigoriadis DE
J Med Chem; 2004 Sep; 47(19):4787-98. PubMed ID: 15341493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
